0001127602-11-030617.txt : 20111129 0001127602-11-030617.hdr.sgml : 20111129 20111129162656 ACCESSION NUMBER: 0001127602-11-030617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111128 FILED AS OF DATE: 20111129 DATE AS OF CHANGE: 20111129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pietrusko Robert CENTRAL INDEX KEY: 0001398219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21699 FILM NUMBER: 111231557 MAIL ADDRESS: STREET 1: 397 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIROPHARMA INC CENTRAL INDEX KEY: 0000946840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232789550 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 STOCKTON DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104587300 MAIL ADDRESS: STREET 1: 730 STOCKTON DRIVE CITY: EXTON STATE: PA ZIP: 19341 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2011-11-28 0000946840 VIROPHARMA INC VPHM 0001398219 Pietrusko Robert 730 STOCKTON DRIVE EXTON PA 19341 1 VP, Regulatory & Quality Common Stock 2011-11-28 4 M 0 19000 9.99 A 22910 D Common Stock 2011-11-28 4 S 0 19000 23.00 D 3910 D Employee Stock Option (Right to Buy) 9.99 2011-11-28 4 M 0 19000 0 D 2009-06-13 2018-06-13 Common Stock 19000 35000 D The options vest in four equal annual installments beginning on the first anniversary date from time of grant. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2011. /s/ J. Peter Wolf, attorney-in-fact 2011-11-29